UroGen Pharma Ltd. — Form D

UroGen Pharma Ltd. of Princeton, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-14. The offering totals $120.0M, of which $120.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2023-08-14
Form: D
Accession: 0001668243-23-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $120.0M
Amount sold: $120.0M
Investors: 8
Date of first sale: 2023-07-26
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-489628

Issuer

Name: UroGen Pharma Ltd.
CIK: 0001668243
Entity type: Corporation
Jurisdiction: ISRAEL
Address: 400 Alexander Park Drive, Princeton, NJ, 08540
Phone: 646-768-9780

Officers, directors & promoters (13)

Name	Role	Location
Elizabeth Barrett	Director	Princeton, NJ
Arie Belldegrun, M.D.	Director	Princeton, NJ
Cynthia Butitta	Director	Princeton, NJ
Fred Cohen, M.D.	Director	Princeton, NJ
Stuart Holden, M.D.	Director	Princeton, NJ
Ran Nussbaum	Director	New York, NY
James A Robinson, Jr.	Director	Princeton, NJ
Leana Wen, M.D., MSc	Director	Princeton, NJ
Dan Wildman	Director	Princeton, NJ
Elizabeth Barrett	Executive Officer	Princeton, NJ
Don Kim	Executive Officer	Princeton, NJ
Mark A Schoenberg, M.D.	Executive Officer	Princeton, NJ
Jason A Smith	Executive Officer	Princeton, NJ

More